Does AMSACRINE Cause Second primary malignancy? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Second primary malignancy have been filed in association with AMSACRINE. This represents 1.3% of all adverse event reports for AMSACRINE.
6
Reports of Second primary malignancy with AMSACRINE
1.3%
of all AMSACRINE reports
4
Deaths
1
Hospitalizations
How Dangerous Is Second primary malignancy From AMSACRINE?
Of the 6 reports, 4 (66.7%) resulted in death, 1 (16.7%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMSACRINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does AMSACRINE Cause?
Off label use (47)
Death (46)
Septic shock (41)
Multiple organ dysfunction syndrome (40)
Acute myeloid leukaemia recurrent (39)
Venoocclusive liver disease (36)
Drug ineffective (35)
Febrile neutropenia (33)
Graft versus host disease (33)
Neutropenia (32)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which AMSACRINE Alternatives Have Lower Second primary malignancy Risk?
AMSACRINE vs ANAGRELIDE
AMSACRINE vs ANAKINRA
AMSACRINE vs ANAMORELIN
AMSACRINE vs ANASTROZOLE
AMSACRINE vs ANDEXANET ALFA